Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma

Cancer Research

Volumn 74, Issue 19, 2014, Pages 5364-5370

  Van Brocklyn, James R ^a   Wojton, Jeffrey ^a   Meisen, Walter H ^a   Kellough, David A ^a   Ecsedy, Jeffery A ^b   Kaur, Balveen ^a   Lehman, Norman L ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; PROTEIN KINASE INHIBITOR;

ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN NEOPLASMS; CELL DIFFERENTIATION; DRUG EFFECTS; DRUG SCREENING; FEMALE; GLIOBLASTOMA; HUMAN; MOUSE; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; AURORA KINASE A; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; FEMALE; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; PROTEIN KINASE INHIBITORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84907495387     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-0386     Document Type: Article

References (26)

1. Marumoto T, Honda S, Hara T, Nitta M, Hirota T, Kohmura E, et al. Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells. J Biol Chem 2003;278:51786-95.
2. Seki A, Coppinger JA, Jang CY, Yates JR, Fang G. Bora and the kinase Aurora A cooperatively activate the kinase Plk1 and control mitotic entry. Science 2008;320:1655-8.
3. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy, and transformation. Nat Genet 1998;20:189-93.
4. Qin L, Tong T, Song Y, Xue L, Fan F, Zhan Q. Aurora-A interacts with cyclin B1 and enhances its stability. Cancer Lett 2009;275:77-85.
5. Sasayama T, Marumoto T, Kunitoku N, Zhang D, Tamaki N, Kohmura E, et al. Overexpression of Aurora-A targets cytoplasmic polyadenylation element binding protein and promotes mRNA polyadenylation of Cdk1 and cyclin B1. Genes Cells 2005;10:627-38.
6. Yang S, He S, Zhou X, Liu M, Zhu H, Wang Y, et al. Suppression of Aurora-A oncogenic potential by c-Myc downregulation. Exp Mol Med 2010;42:759-67.
7. Carol H, Boehm I, Reynolds CP, Kang MH, Maris JM, Morton CL, et al. Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer. Cancer Chemother Pharmacol 2011;68:1291-304.
8. Görgün G, Calabrese E, Hideshima T, Ecsedy J, Perrone G, Mani M, et al. A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma. Blood 2010;115:5202-13.
9. Huck JJ, Zhang M, McDonald A, Bowman D, Hoar KM, Stringer B, et al. MLN8054, an inhibitor of Aurora A kinase, induces senescence in human tumor cells both in vitro and in vivo. Mol Cancer Res 2010;8:373-84.
10. ClinicalTrials.gov, a service of the U. S. National Institutes of Health. Available from: http://www.cancer.gov/clinicaltrials/search/results? protocolsearchid=13117883.
11. Ando R, Ikegami H, Sakiyama M, Ooike S, Hayashi M, Fujino Y, et al. 3-Cyano-6-(5-methyl-3-pyrazoloamino) pyridines: selective Aurora A kinase inhibitors. Bioorg Med Chem Lett 2010;20:4709-11.
12. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004;64:7011-21.
13. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006;9:391-403.
14. Hong X, O'Donnell JP, Salazar CR, Van Brocklyn JR, Barnett KD, Pearl DK, et al. The selective Aurora-A kinase inhibitor MLN8237 (alisertib) potently inhibits proliferation of glioblastoma neurosphere tumor stemike cells and potentiates the effects of temozolomide and ionizing radiation. Cancer Chemother Pharmacol 2014;73:983-90.
15. Lehman NL, O'Donnell JP, Whiteley LJ, Stapp RT, Lehman TD, Roszka KM, et al. Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas. Cell Cycle 2012;11:489-502.
16. Biesterfeld S, Beckers S, Del Carmen Villa Cadenas M, Schramm M. Feulgen staining remains the gold standard for precise DNA image cytometry. Anticancer Res 2011;31:53-8.
17. Walter AO, Seghezzi W, Korver W, Sheung J, Lees E. The mitotic serine/threonine kinase Aurora2/AIK is regulated by phosphorylation and degradation. Oncogene 2000;19:4906-16.
18. Moustafa-Kamal M, Gamache I, Lu Y, Li S, Teodoro JG. BimEL is phosphorylated at mitosis by Aurora Aand targeted for degradation by bTrCP1. Cell Death Differ 2013;20:1393-403.
19. Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 2008;28:264-78.
20. Romanov VS, Pospelov VA, Pospelova TV. Cyclin-dependent kinase nhibitor p21 (Waf1): contemporary view on its role in senescence and oncogenesis. Biochemistry 2012;77:575-84.
21. Sakakibara S, Nakamura Y, Yoshida T, Shibata S, Koike M, Takano H, et al. RNA-binding protein Musashi family: roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation. Proc Natl Acad Sci USA 2002;99:15194-9.
22. high glioma-initiating cell population in human glioblastoma. Cancer Cell 2010;18:655-68.
23. Chenn A, Walsh CA. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 2002;297:365-9.
24. Gilyarov AV. Nestin in central nervous system cells. Neurosci Behav Physiol 2008;38:165-9.
25. Lee DF, Su J, Ang YS, Carvajal-Vergara X, Mulero-Navarro S, Pereira CF, et al. Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling. Cell Stem Cell 2012;11:179-94.
26. Hoar K, Chakravarty A, Rabino C, Wysong D, Bowman D, Roy N, et al. MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy. Mol Cell Biol 2007;27:4513-25.